News
The next South Carolina death row inmate set to be executed – a killer in a case with ties to Augusta – has selected lethal ...
19h
WCIV on MSNSouth Carolina inmate chooses to die by lethal injection amid concerns about firing squadSouth Carolina death row inmate Stephen Stanko on Friday chose to die by lethal injection after his lawyers said he was ...
Japanese drugmaker Sumitomo Pharma (TYO: 4506) and Denmark’s Novo Nordisk (NOV: N) have entered into a co-promotion agreement ...
The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...
An oncology nurse shares advice for avoiding exhaustion and soreness when administering subcutaneous injections.
The extended injection time for subcutaneous daratumumab in those with myeloma can serve as an opportunity for oncology nurses to check in with patients.
A new treatment option for people with multiple sclerosis could alleviate resource strains on New Zealand's health system.
"We are delighted that the subcutaneous injection of VYVGART® co-formulated with our ENHANZE drug delivery technology, has been recommended for approval in the European Union. The positive CHMP ...
Hooven, Chairman and CEO of Enable Injections. “Our enFuse platform is uniquely positioned to address challenges in developing large-volume subcutaneous oncology drugs. This wearable delivery ...
Notably, this interview came following the Dec. 27, 2024, Food and Drug Administration (FDA) approval of the subcutaneous injection formulation of Opdivo for patients with solid tumors. Intravenous ...
For patients, for example, who had to previously travel long distances for IV treatments, they now may be able to receive these subcutaneous under the skin injections locally. Because Opdivo is now ...
for subcutaneous injection across approved nivolumab (Opdivo) indications for adult, solid tumors as monotherapy, monotherapy maintenance following completion of nivolumab plus ipilimumab (Yervoy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results